Advertisement
Webcast Instructions
To access the live webcast, visit the company Web site at www.kendle.comor link to the Webcast directly athttp://www.videonewswire.com/event.asp?id=50021 . Instructions for accessingthe webcast are provided at both sites. The webcast will be archived athttp://www.kendle.com (click on "Investors" and then "Events & Presentations")shortly after the call for on-demand replay through 5 p.m. Eastern Time onSept. 5, 2008. Please note that webcast participants will not be able to askquestions.
Advertisement
System requirements for the webcast include Windows Media Player softwareand at least a 28.8 Kbps connection to the Internet. Media Player isdownloadable at no charge fromhttp://www.microsoft.com/windows/windowsmedia/default.aspx .
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadianparticipants should dial (800) 223-7104. Participants outside North Americashould dial (706) 645-6519.
To participate in the telephone conference call, interested parties in theUnited States and Canada should dial (800) 399-0069. Participants outsideNorth America should dial (706) 643-3694. A replay will be available through 5p.m. Eastern Time on Sept. 5 by dialing (706) 645-9291 and entering conferenceID number 55347808.
About Kendle
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinicalresearch organization providing the full range of early- to late-stageclinical development services for the world's biopharmaceutical industry. Ourfocus is on innovative solutions that reduce cycle times for our customers andaccelerate the delivery of life-enhancing drugs to market for the benefit ofpatients worldwide. As one of the fastest-growing global providers of PhaseI-IV services, we offer experience spanning 90 countries, along withindustry-leading patient access and retention capabilities and broadtherapeutic expertise, to meet our customers' clinical developmentchallenges. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 byleading global pharmaceutical publication Scrip World Pharmaceutical News.
Additional information and investor kits are available upon request fromKendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from thecompany's Web site at http://www.kendle.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )CINCINNATI, July 16 /PRNewswire-FirstCall/ -- CALL DATE: Wednesday, Aug. 6, 2008 TIME: 9:30 a.m. Eastern Time HOST: Dr. Candace Kendle, Chairman and CEO
SOURCE Kendle International Inc.
